Efagins: engineerable agents that evolved independently to target the enterococcal cell wall
Janira Prichula, Abigail L. Manson, Joshua T. Smith…·Michael S. Gilmore
The paper identifies efagins, a new class of antibacterial agents that target enterococcal cell wall carbohydrates, and shows they can be engineered for alternative receptor targeting.